MAZE – maze therapeutics, inc. (US:NASDAQ)

News

Maze Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Maze Therapeutics SVP Sells 5,000 Shares Amid Historic First Year for the Company's Stock [Yahoo! Finance]
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Maze Therapeutics (NASDAQ:MAZE) was upgraded by analysts at Wall Street
Maze Therapeutics (NASDAQ:MAZE) was downgraded by analysts at Wall Stree
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com